ClearPoint Neuro, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
ClearPoint Neuro, Inc. (CLPT) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of $7.26 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2026-03-17
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2025 was $7.26, a 10.26% decline from fiscal 2024.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2024 was $8.09, a 36.42% increase from fiscal 2023.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2023 was $5.93, a 14.92% increase from fiscal 2022.
- ClearPoint Neuro, Inc. share-based compensation arrangement by share-based payment award, options, vested, weighted average grant date fair value for fiscal 2022 was $5.16, a 156.72% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|
| 2025-12-31 | $7.26 10-K · filed 2026-03-17 | |
| 2024-12-31 | $8.09 10-K · filed 2025-02-26 | |
| 2023-12-31 | $5.93 10-K · filed 2024-03-12 | |
| 2022-12-31 | $5.16 10-K · filed 2023-03-01 | |
| 2021-12-31 | $2.01 10-K · filed 2022-03-09 | |
| 2020-12-31 | $1.50 10-K · filed 2021-03-22 | |
| 2019-12-31 | $1.35 10-K · filed 2021-03-22 | |
| 2018-12-31 | $1.71 10-K · filed 2020-03-27 | |
| 2017-12-31 | $3.09 10-K · filed 2019-04-01 | |
| 2016-12-31 | $18.16 10-K · filed 2018-03-21 | |
| 2015-12-31 | $21.13 10-K · filed 2017-03-09 | $0.53 10-K · filed 2016-03-25 |
| 2014-12-31 | $0.58 10-K · filed 2016-03-25 | $0.50 10-K · filed 2015-03-17 |
| 2013-12-31 | $0.58 10-K · filed 2015-03-17 | |
| 2012-12-31 | $1.04 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |